Psychodermatological aspects of atopic dermatitis

British Journal of Dermatology

Volumn 170, Issue SUPPL. 1, 2014, Pages 38-43

  Senra, M S ^a   Wollenberg, A ^b  

^a Glaucoma and Cataract Sector   (Brazil)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; CATECHOLAMINE DERIVATIVE; CORTICOTROPIN; GLUCOCORTICOID; HYDROCORTISONE;

ANXIETY; ATOPIC DERMATITIS; CAREGIVER; COMORBIDITY; DEPRESSION; DERMATOLOGIST; DOCTOR PATIENT RELATION; HORMONE RESPONSE; HUMAN; PATIENCE; PATIENT CARE; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOLOGIST; PSYCHOSOCIAL WITHDRAWAL; PSYCHOTRAUMA; QUALITY OF LIFE; REVIEW; SOCIAL STIGMA; STRESS; SYMPTOMATOLOGY; COMPLICATION; DERMATITIS, ATOPIC; IMMUNITY; MENTAL STRESS; PHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PROCEDURES; PRURITUS; PSYCHOLOGY; PSYCHOTHERAPY;

DERMATITIS, ATOPIC; HUMANS; IMMUNITY; PHYSICIAN-PATIENT RELATIONS; PRURITUS; PSYCHOTHERAPY; QUALITY OF LIFE; STRESS DISORDERS, TRAUMATIC; STRESS, PSYCHOLOGICAL;

EID: 84902799815     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13084     Document Type: Review

References (53)

1. Jafferany M,. Psychodermatology: a guide to understanding common psychocutaneous disorders. Prim Care Companion J Clin Psychiatry 2007; 9: 203-13.
2. Picardi A, Mazzotti E, Pasquini P,. Prevalence and correlates of suicidal ideation among patients with skin disease. J Am Acad Dermatol 2006; 54: 420-6.
3. Ponarovsky B, Amital D, Lazarov A, et al,. Anxiety and depression in patients with allergic and non-allergic cutaneous disorders. Int J Dermatol 2011; 50: 1217-22.
4. Humphreys F, Humphreys MS,. Psychiatric morbidity and skin disease: what dermatologists think they see. Br J Dermatol 1998; 139: 679-81.
5. Morren MA, Przybilla B, Bamelis M, et al,. Atopic dermatitis: triggering factors. J Am Acad Dermatol 1994; 31: 467-73.
6. Chida Y, Hamer M, Steptoe A,. A bidirectional relationship between psychosocial factors and atopic disorders: a systematic review and meta-analysis. Psychosom Med 2007; 70: 102-16.
7. Koo JYM, Lee CS,. General approach to evaluating psychodermatological disorders. In: Psychocutaneous Medicine (, Koo JYM, Lee CS, eds). New York: Marcel Dekker, 2003; 1-29.
8. Griesemer R,. Emotionally triggered disease in a dermatologic practice. Psychiatr Ann 1978; 8: 407-12.
9. Faulstich ME, Williamson DA,. An overview of atopic dermatitis: toward a bio-behavioural integration. J Psychosom Res 1985; 29: 647-54.
10. Ständer S, Raap U, Weisshaar E, et al,. Pathogenesis of pruritus. J Dtsch Dermatol Ges 2011; 9: 456-63.
11. Arck PC, Slominski A, Theoharides TC, et al,. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 2006; 126: 1697-704.
12. Misery L,. Neuro-immuno-cutaneous system (NICS). Pathol Biol (Paris) 1996; 44: 867-74.
13. Garg A, Chren MM, Sands LP, et al,. Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol 2001; 137: 53-9.
14. Selye H,. The general adaptation syndrome and the diseases of adaptation. J Clin Endocrinol Metab 1946; 6: 117-230.
15. Pavlovic S, Liezmann C, Blois SM, et al,. Substance P Is a key mediator of stress-induced protection from allergic sensitization via modified antigen presentation. J Immunol 2011; 186: 848-55.
16. Peters EMJ,. The neuroendocrine-immune connection regulates chronic inflammatory disease in allergy. Chem Immunol Allergy 2012; 98: 240-52.
17. Tausk F, Elenkov I, Moynihan J,. Psychoneuroimmunology. Dermatol Ther 2008; 21: 22-31.
18. Toyoda M, Nakamura M, Makino T, et al,. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002; 147: 71-9.
19. Baldwin AL,. Mast cell activation by stress. Methods Mol Biol 2006; 315: 349-60.
20. Elias PM, Sun R, Eder AR, et al,. Treating atopic dermatitis at the source: corrective barrier repair therapy based upon new pathogenic insights. Expert Rev Dermatol 2013; 8: 27-36.
21. Altemus M, Rao B, Dhabhar FS, et al,. Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol 2001; 117: 309-17.
22. Choi E-H, Brown BE, Crumrine D, et al,. Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J Invest Dermatol 2005; 124: 587-95.
23. Dawn A, Papoiu ADP, Chan YH, et al,. Itch characteristics in atopic dermatitis: results of a web-based questionnaire. Br J Dermatol 2009; 160: 642-4.
24. Yosipovitch G, Ishiuji Y, Patel TS, et al,. The brain processing of scratching. J Invest Dermatol 2008; 128: 1806-11.
25. Raap U, Kapp A,. Neurotrophins in healthy and diseased skin. G Ital Dermatol Venereol 2010; 145: 205-11.
26. Dieris-Hirche J, Gieler U, Kupfer JP, Milch WE,. Suicidal ideation, anxiety and depression in adult patients with atopic dermatitis. Hautarzt 2009; 60: 641-6.
27. Gupta MA, Gupta AK,. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol 2003; 4: 833-42.
28. Ellis CN, Mancini AJ, Paller AS, et al,. Understanding and managing atopic dermatitis in adult patients. Semin Cutan Med Surg 2012; 31: S18-22.
29. Anon. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41: 1403-9.
30. Rapp SR, Feldman SR, Exum ML, et al,. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 401-7.
31. Hong J, Koo B, Koo J,. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther 2008; 21: 54-9.
32. Beattie PE, Lewis-Jones MS,. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol 2006; 155: 145-51.
33. Daud LR, Garralda ME, David TJ,. Psychosocial adjustment in preschool children with atopic eczema. Arch Dis Child 1993; 69: 670-6.
34. Jafferany M,. Psychodermatology: When the mind and skin interact. Available at: http://www.psychiatrictimes.com/psychodermatology-when-mind-and- skin-interact (last accessed 23 April 2014).
35. Lapidus CS, Kerr PE,. Social impact of atopic dermatitis. Med Health R I 2001; 84: 294-5.
36. Williams DH,. Management of atopic dermatitis in children; control of maternal rejection factor. AMA Arch Dermatol Syphilol 1951; 63: 545-60.
37. Kodama A, Horikawa T, Suzuki T, et al,. Effect of stress on atopic dermatitis: investigation in patients after the great hanshin earthquake. J Allergy Clin Immunol 1999; 104: 173-6.
38. Sandberg S, Paton JY, Ahola S, et al,. The role of acute and chronic stress in asthma attacks in children. Lancet 2000; 356: 982-7.
39. Willemsen R, Roseeuw D, Vanderlinden J,. Alexithymia and dermatology: the state of the art. Int J Dermatol 2008; 47: 903-10.
40. Kooiman CG, van Rees Vellinga S, Spinhoven P, et al,. Childhood adversities as risk factors for alexithymia and other aspects of affect dysregulation in adulthood. Psychother Psychosom 2004; 73: 107-16.
41. Van der Kolk BA,. The neurobiology of childhood trauma and abuse. Child Adolesc Psychiatr Clin N Am 2003; 12: 293-317.
42. Gupta MA,. Somatization disorders in dermatology. Int Rev Psychiatry 2006; 18: 41-7.
43. Poot F,. Doctor-patient relations in dermatology: obligations and rights for a mutual satisfaction. J Eur Acad Dermatol Venereol 2009; 23: 1233-9.
44. Misery L,. The role of dermatologist in adherence to treatment. Ann Dermatol Venereol 2012; 139 (Suppl. 1): S18-21.
45. Hajjaj FM, Salek MS, Basra MKA, Finlay AY,. Clinical decision making in dermatology: observation of consultations and the patients' perspectives. Dermatology 2010; 221: 331-41.
46. Ainsworth M, Blehar M, Waters E, Wall S,. Patterns of Attachment: A Psychological Study of the Strange Situation. Hillsdale, NJ: Lawrence Erlbaum, 1978.
47. Fonagy P,. Attachment, the development of the self, and its pathology in personality disorders. Psychomedia 1996; 129: 26-32.
48. Harth W, Gieler U, Kusnir D, Tausk FA,. Clinical Management in Psychodermatology. Berlin: Springer, 2008.
49. Rizzolatti G, Craighero L,. The mirror-neuron system. Annu Rev Neurosci 2004; 27: 169-92.
50. Barbarot S, Stalder J,. Therapeutic patient education in atopic eczema. Br J Dermatol 2014; 170 (Suppl. 1): 44-48.
51. Shenefelt PD,. Hypnosis in dermatology. Arch Dermatol 2000; 136: 393-9.
52. Linnet J, Jemec GB,. Anxiety level and severity of skin condition predicts outcome of psychotherapy in atopic dermatitis patients. Int J Dermatol 2001; 40: 632-6.
53. Hall JMF, Cruser D, Podawiltz A, et al,. Psychological stress and the cutaneous immune response: roles of the HPA axis and the sympathetic nervous system in atopic dermatitis and psoriasis. Dermatol Res Pract 2012; 2012: 403908.